Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Ophiasis mainly affects females, lasts longer, and has lower regrowth rates, with a new classification system helping predict treatment response.

Upadacitinib can effectively regrow hair in alopecia areata patients without worsening sarcoidosis.

Special cells can help regrow hair in alopecia areata.

Targeting gut microbiome and metabolome may help treat autoimmune skin diseases like alopecia areata.

Most patients improved in both atopic dermatitis and alopecia areata with certain treatments, but some had worsened symptoms, suggesting personalized care is needed.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Mesenchymal Stem Cell therapy shows promise for treating hair loss in Alopecia Areata.

Lasers and energy-assisted methods show promise for treating hair loss, but more research is needed.

Tofacitinib is a safe and effective treatment for hair loss in children with Alopecia Areata.

Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.

Mesenchymal Stem/Stromal Cells (MSCs) help in wound healing and tissue regeneration, but can also contribute to tumor growth. They show promise in treating chronic wounds and certain burns, but their full healing mechanisms and potential challenges need further exploration.

Baricitinib is a promising treatment for severe alopecia areata with minimal side effects.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

308 excimer phototherapy is a safe and effective way to treat hair loss from Alopecia Areata.

Cyclophosphamide is preferred for severe cases in pediatric rheumatology and nephrology despite its side effects.

Combination pharmacotherapy is generally more effective for treating keloids and hypertrophic scars.

Provenge extends prostate cancer survival by about 4 months.

OnabotulinumtoxinA is used to treat wrinkles, pain, sweating, hair loss, and more by temporarily paralyzing muscles and affecting pain pathways.

A new surgical technique effectively cures acne in most patients.

A child has a rare hair and skin disorder due to specific gene variants, suggesting broader genetic testing is needed.

A severe medication reaction required long treatment and led to hair loss and thyroid issues.

A cosmetic procedure can lower the hairline by up to 10 cm, with high satisfaction but potential for temporary sensation loss and rare risks.

Baricitinib helps regrow scalp, eyebrow, and eyelash hair in teens with severe alopecia areata.

Some treatments can help hair regrowth in alopecia areata, but none offer a cure, and effectiveness varies.

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

Upadacitinib may cause hair loss.

Alopecia areata causes unpredictable hair loss and emotional distress, with no cure and limited treatment options.

Current treatments for alopecia areata can help hair grow but don't cure the disease.